Published February 28, 2017
| Published
Journal Article
Open
Biomarkers for Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.
Additional Information
© 2017 The Author(s). Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Received: September 20, 2016. Accepted: November 26, 2016. Published on 28 Feb 2017. The author(s) received no financial support for the research, authorship, and/or publication of this article. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Author Contributions: All the authors conceived, organized, drafted, reviewed, and approved the manuscript.Attached Files
Published - f_10.1177_1179299X16684640.pdf_8293.pdf
Files
f_10.1177_1179299X16684640.pdf_8293.pdf
Files
(498.8 kB)
Name | Size | Download all |
---|---|---|
md5:3353b54e02faa5676aeaaa818e2cca12
|
498.8 kB | Preview Download |
Additional details
- PMCID
- PMC5345949
- Eprint ID
- 77298
- Resolver ID
- CaltechAUTHORS:20170509-102347515
- Created
-
2017-05-12Created from EPrint's datestamp field
- Updated
-
2022-04-04Created from EPrint's last_modified field